May 14, 2024 / 09:00PM GMT
Operator
Good afternoon. My name is Josh, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences conference call for the first quarter ended March 31, 2024. (Operator Instructions) As a reminder, this conference call may be recorded.
I would like to introduce Ms. Susan Pietropaolo, please go ahead.
Susan Pietropaolo Aptose Biosciences Inc-IR
Thank you, Josh. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended March 31, 2024. Earlier today, Aptose issued a press release relating to the financial results. The news release, as well as related SEC filings are accessible on Aptose's website.
Joining me on today's call are Dr. William Rice, Chairman, President and CEO; Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer and Chief Business Officer.
Before we proceed, I would like to remind everyone that certain
Q1 2024 Aptose Biosciences Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot